"Strategy Inc was able to perform a market analysis and technology assessment that permitted our company to monetize our intellectual property outside of our clinical focus."

"Strategy Inc. was recommended by our attorneys Stradling, Yocca, Carlson & Rauth, and we hired them to perform a valuation on our novel technology. They delivered an in-depth analysis and valuation based on solid market data triangulated to support a position of strength for the negotiations. Strategy Inc delivered ten year financial projections for US and OUS, that were solid. Strategy Inc is a top quality company that I would recommend highly!"

"Strategy Inc has worked with a number of my companies on a variety of important strategic projects. I have found them extremely thorough in helping us isolate the true objectives of what we are attempting to gain from a study, crystallize our thought process in executing the study and factually analyze the results for our management teams.

We have worked with Strategy Inc. in projects that have focused our product development activities into new directions (e.g., Vertelink Corporation), brought together a worldwide group of scientific experts for clinical and technical feedback (e.g., Devax, Inc.) and shaped our sales and marketing strategy for a major new product launch (e.g., Micrus Endovascular Corporation)."

"Strategy Inc. helped us to get a handle on an emerging therapeutic solution that provides a complete paradigm shift – a revolutionary, not evolutionary approach. A Clinical Assessment with global leaders confirmed several of our assumptions, and also uncovered different priorities that will drive our strategy. In addition, several alternative opportunities for positioning were unearthed. I am pleased with the work performed by Strategy Inc."

"Strategy Inc. assisted our company with the development of an Investor Presentation and a Valuation Top Line clarifying the value proposition of our novel technologies. Strategy Inc. also performed due diligence to support closing our first round 6 Million Euros investment from Ysios Capital Partners, La Caixa and ICO Axis - an exciting time for our company. We sincerely appreciated the efforts and deliverables of Strategy Inc. and are pleased to be able to move to the next stage of our development.

"Prior to allocating additional resources for expansion of our product portfolio, Strategy Inc. performed a worldwide market due diligence analysis to validate clinical need and market perceptions. The project entailed numerous decision makers and influencers in the complicated critical care environment. Strategy Inc. was able to drill down to the key issues that would enable us to make a decision based on the results of their work.

Their thorough analysis covering a range of stakeholders across the globe enabled our team to make strategic decisions with confidence by confirming several assumptions, quantifying market need and discovering key trends to ensure successful positioning of our technology."

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring selling medical technologies in nearly 100 countries with 2010 sales of $1.45 billion.

"Strategy Inc performed a TechSelect Analysis on eight of our developing technologies at LA BioMed, the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. This in depth business analysis provided a framework for successful commercialization for a wide range of technologies at very different stages of development and is incredibly helpful. "

"Strategy Inc. performed a business analysis for several of our biologic emerging technologies delivering a US market strategy. The due diligence with targeted key opinion leaders in a cross section of clinical subspecialties provided valuable perspective for market segments under consideration. Strategy Inc. also executed several competitive business analyses that included a pricing strategy to help define the US market opportunity for our technologies. Strategy Inc. consistently delivers very precise and strategic work, and we continue to design our US strategy with their insight."

"We needed a more in depth industry analysis and comparison on where we stood against the competition and market trends, as we were preparing to expand our market share with a new product line. Strategy Inc. delivered on time and budget, much more than was expected. This gave us the ability to execute our strategy with confidence. Strategy Inc.'s team became a part of our team."

"Strategy Inc's seasoned market analysis and insight steers companies toward successful strategic decisions."

"The highly professional, structured and focused process of competitive analysis conducted by Strategy Inc. contributed significantly and brought certainty to our business decisions. We felt we were provided with clear thinking and expert advice, which helped us identify the best opportunities for growth and performance.

Strategy Inc. is the home of informed decisions, providing the reassurance that the Market Assessment and Competitive Analysis are performed at the highest professional level. [Strategy Inc's] consistent insight and focused direction provide a starting point for shaping future performance."

"I have engaged Strategy Inc. on multiple consulting projects at two medical device companies. To sum it up, Strategy Inc. delivers. They consistently deliver high quality analysis with exceptional attention to detail on time, every time. I would, without reservation, recommend them to anyone seeking market assessments, business planning, competitive analysis, and strategic direction."

"In working with Strategy Inc on marketing claims analysis and market research, we found that their processes and hard work consistently developed results which gave a comprehensive view of the market space, and that their style as a company yielded deliverables with exceptional clarity and utility."

"Strategy Inc. conducted several valuable medical device assessments that were critical in our evaluation of new project proposals. They provided us with thorough research and strategic analyses, including: market potential, competition, regulatory affairs, intellectual property, reimbursement, and opinions from leading clinicians."

"Strategy Inc. prepared an extensive
(135 pages) new market assessment for a new product we are contemplating. The report is extremely helpful with considerations of all critical success factors that we have reached a positive decision to go ahead with the project. I would highly recommend anyone contemplating a new product to engage Strategy Inc. for such an analysis."

"I have used Strategy Inc. to augment the capabilities of my own small group to conduct market opportunity assessments, validate new product concepts, and collect voice of customer and key opinion leader feedback. Strategy Inc. has worked on our behalf with a number of different medical specialties here in North America, as well as Asia and Latin America. Strategy Inc. collaborates closely with clients to develop a deep understanding of the project, then works independently to achieve project objectives and meet project deadlines. The work done by Strategy Inc. is of exceptional quality. I am extremely pleased with the results we have achieved in collaboration with Strategy Inc. and the extent to which we have been able to leverage my small team's effectiveness."